Although various factors activate mTOR signaling, this study focused on two mTOR regulatory mechanisms: anti-cancer drug-induced mTOR signaling and L-type amino acid transporter 1 (LAT1) (also referred to as SLC7A5)-induced mTOR activation [14]. This evidence concerns the gene SLC7A5 and cancer.